1Stephen T. Humer, Eric Boerwinkle. Genetics of hypertension, target-organ complication, and response to therapy. Circulation, 2000,102: Ⅳ40-Ⅳ45.
2Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left vent ricular hypertrophy. N Engl J Med, 1994,330(23): 1634-1638.
3Kimura M, Yokota M, Fujimura T, et al. Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in japanese women with essential hypertension; multicenter study of 1,919 subjects. Cardiology, 1997,88(4) :309-314.
4Iwai N, Ohmichi N, Nakamura Y, et al. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation, 1994,90(6) :2622-2628.
5Prasad N,O'Kane KP,Johnstone HA, et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the pressence of the angiotensin-converting enzyme gene deletion allele. QJM, 1994,87(11) : 659 -- 662.
6Wong KK,Summers KM,Burstow DJ,et al. Genetic variants of proteins from the renin angiotesin system are assosiated with pressure load cardiac hypertrophy. Clin Exp Pharmacol Physiol, 1996,23(6-7) :587--590.
7West MJ, Summers KM, Wong KK, et al. Renin-angiotensin system gene polymorphisms and left ventricular hypertrophy. The case against an association. Adv Exp Med Biol, 1997,432:117-122.
8Perticone F, Ceravolo R,Cosco C,et al. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern italian patients. J Am Coll Cardiol, 1997,29(2) :365--369.
9Kuznetsova T, Staessen JA, Wang JG, et al. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphima and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens, 2000,14(7) :447-454.
10Celentao A, Mancini FP, palmieri V, et al. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol, 1999,83(8):1196--1200.
同被引文献20
1Castellano M,Muiesan ML,Beschi M,et al.Angiotensin Ⅱtype 1 receptor A/C1166 polymorphis.Relationships with blood pressure and cardiovascular structure.Hypertension, 1996, 28(6):1076.
2Takami S,Katsuya T,Rakugi H,et al.The angiotensin Ⅱtype 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension.Am J Hypertens,1998,11(3 Pt 1):316-321.
3Ashavaid TF,Shalia KK,Nair KG,et al.ACE and AT1R gene polymorphisms and hypertension in Indian poupulation.J Clin Lab Anal,2000,14(5):230-237.
4Wang WY,Zee RY,Morris BJ.Association of angiotensin Ⅱtype 1 receptor gene polymorphism with essential hypertension[J].Clin Genet,1997,51(1):31-34.
5Kainulainen K,Perola M,Terwilliger J,et al.Evidence for involvement of the type 1 angiotensin Ⅱ receptor locus in essential hypertension[J].Hypertension,1999,33(3):844-849.
6Schmidt S,Beige J,Walla-Friedel M,et al.A polymorphism in the gene for the angiotensin Ⅱtype 1 receptor is not associated with hypertensin[J].J Hpertension,1997,15(12 Pt 1):1 385.
7Bonnardeau A,Davies E,Jeunemaitre X,et al.AngiotensinⅡ type Ⅰreceptor gene polymorphisms in human essential hypertension[J].Hypertension,1994,24(1):63-69.
8罗会元主译.人类遗传学[M](第3版)[M].北京:人民卫生出版社,1999.749-750.
9Egger M,Davey SG,Schneider M,et al.Bias in meta-analysis detected by a simple,graphical test[J].BMJ,1997,315(9):629-634.
